MAZE logo

Maze Therapeutics, Inc. (MAZE) Cash From Investing

Annual CFI:

-$1.15M-$706.00K(-160.09%)
December 31, 2024

Summary

  • As of today, MAZE annual cash from investing is -$1.15 million, with the most recent change of -$706.00 thousand (-160.09%) on December 31, 2024.
  • During the last 3 years, MAZE annual cash from investing has risen by +$2.02 million (+63.82%).
  • MAZE annual cash from investing is now -160.09% below its all-time high of -$441.00 thousand, reached on December 31, 2023.

Performance

1-Year Change

-160.09%

3-Year Change

+63.82%

5-Year Change

+63.82%

15-Year Change

+63.82%

MAZE Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

43.82%
MAZE annual cash from investing is higher than 43.82% of companies in Healthcare sector

Range

All-Time High

-$441.00K
MAZE annual cash from investing is currently -160.09% below its historical high of -$441.00 thousand

3-Year Low

-$3.17M
MAZE annual cash from investing is currently +63.82% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
MAZE previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
MAZE next annual earnings announcement has not yet been scheduled

OtherMAZEcash flow metrics

Annual CFF

$92.85M
MAZE annual cash from financing is $92.85 million

Annual CFO

$75.95M
MAZE annual cash from operations is $75.95 million

Annual FCF

$74.81M
MAZE annual free cash flow is $74.81 million

Annual CAPEX

$1.15M
MAZE annual capital expenditures is $1.15 million

Quarterly CFI:

-$393.00K-$94.00K(-31.44%)
June 30, 2025

Summary

  • As of today, MAZE quarterly cash from investing is -$393.00 thousand, with the most recent change of -$94.00 thousand (-31.44%) on June 30, 2025.
  • Over the past year, MAZE quarterly cash from investing has dropped by -$233.00 thousand (-145.62%).
  • MAZE quarterly cash from investing is now -1055.88% below its all-time high of -$34.00 thousand, reached on December 31, 2023.

Performance

3-Month Change

-31.44%

1-Year Change

-145.62%

3-Year Change

+3.44%

5-Year Change

+3.44%

MAZE Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

35.71%
MAZE quarterly cash from investing is higher than 35.71% of companies in Healthcare sector

Range

All-Time High

-$34.00K
MAZE quarterly cash from investing is currently -1055.88% below its historical high of -$34.00 thousand

3-Year Low

-$605.00K
MAZE quarterly cash from investing is currently +35.04% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
MAZE previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 11, 2025
MAZE next earnings announcement is scheduled for Nov 11, 2025

OtherMAZEcash flow metrics

Quarterly CFF

$612.00K
MAZE quarterly cash from financing is $612.00 thousand

Quarterly CFO

-$30.05M
MAZE quarterly cash from operations is -$30.05 million

Quarterly FCF

-$30.45M
MAZE quarterly free cash flow is -$30.45 million

Quarterly CAPEX

$393.00K
MAZE quarterly capital expenditures is $393.00 thousand

TTM CFI:

-$1.30M-$233.00K(-21.90%)
June 30, 2025

Summary

  • As of today, MAZE TTM cash from investing is -$1.30 million, with the most recent change of -$233.00 thousand (-21.90%) on June 30, 2025.
  • Over the past year, MAZE TTM cash from investing has dropped by -$417.00 thousand (-47.39%).
  • MAZE TTM cash from investing is now -218.67% below its all-time high of -$407.00 thousand, reached on September 1, 2023.

Performance

3-Month Change

-21.9%

1-Year Change

-47.39%

3-Year Change

-218.67%

5-Year Change

-218.67%

MAZE TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

39.38%
MAZE TTM cash from investing is higher than 39.38% of companies in Healthcare sector

Range

All-Time High

-$407.00K
MAZE TTM cash from investing is currently -218.67% below its historical high of -$407.00 thousand

3-Year Low

-$1.30M
MAZE TTM cash from investing is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
MAZE previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 11, 2025
MAZE next earnings announcement is scheduled for Nov 11, 2025

OtherMAZEcash flow metrics

TTM CFF

$198.25M
MAZE TTM cash from financing is $198.25 million

TTM CFO

-$82.02M
MAZE TTM cash from operations is -$82.02 million

TTM FCF

-$83.32M
MAZE TTM free cash flow is -$83.32 million

TTM CAPEX

$1.30M
MAZE TTM capital expenditures is $1.30 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MAZE Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-160.1%-145.6%-47.4%
3Y3 Years+63.8%+3.4%-218.7%
5Y5 Years+63.8%+3.4%-218.7%

MAZE Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-160.1%+63.8%-1055.9%+35.0%-218.7%at low
5Y5-Year-160.1%+63.8%-1055.9%+35.0%-218.7%at low
All-TimeAll-Time-160.1%+63.8%-1055.9%+35.0%-218.7%at low

MAZE Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$393.00K(-31.4%)
-$1.30M(-21.9%)
Mar 2025
-
-$299.00K(+50.6%)
-$1.06M(-1.9%)
Dec 2024
-$1.15M
-$605.00K(-278.1%)
-$1.04M(-18.6%)
Jun 2024
-
-$160.00K(+42.7%)
-$880.00K(-22.2%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$279.00K(-720.6%)
-$720.00K(-63.3%)
Dec 2023
-$441.00K(+86.1%)
-$34.00K(+91.6%)
-$441.00K(-8.4%)
Sep 2023
-
-$407.00K
-$407.00K
Dec 2022
-$3.17M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Maze Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Maze Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of MAZE is -$1.15M

What is the all-time high annual cash from investing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual cash from investing is -$441.00K

What is Maze Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, MAZE annual cash from investing has changed by -$706.00K (-160.09%)

What is Maze Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of MAZE is -$393.00K

What is the all-time high quarterly cash from investing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly cash from investing is -$34.00K

What is Maze Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, MAZE quarterly cash from investing has changed by -$233.00K (-145.62%)

What is Maze Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of MAZE is -$1.30M

What is the all-time high TTM cash from investing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM cash from investing is -$407.00K

What is Maze Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, MAZE TTM cash from investing has changed by -$417.00K (-47.39%)
On this page